ViaGen Pets

Um, you know, uh, we have an incredible team that takes care of things like woolly mice, right? And these are things that we, we didn't have.

But there is so much, and I think that's the value that we've built is we try to look at this from a vertical integration first principles perspective of looking at we had to own the entire stack, right? So that's why, like, when we were looking at expanding our endangered species production, our biobanking and BioVault initiative, uh, and kind of our global network that we've been rolling out, buying Viagen made a lot of sense, right? When you look at, like, animal cloning, most people it's dogs, cats, and horses, but there were, like, two.

There was Viagen in the US and, and then there was a company in South Korea.

Um, and so there was, like, really two.

Well, Viagen had, like, cloning efficiencies at 80% where most people are at 2%, right? And so i- it made sense for us to say, "Okay, we need to buy them and bolt them on from a vertical integration perspective." So, so much of the supply chain we've either built, innovated, licensed, or bought, but you, I, you got a taste of it today.

We had to bui- We, we've, we've put the entire thing under one roof, and I think that cross-disciplinary function of allowing people to work, you know, from everything from animal ops to ancient DNA extraction and everything in the middle makes the products go faster and, and better.

So we have to let our furry friends go.